Patient experience at a dedicated multidisciplinary non-alcoholic fatty liver disease (nafld) clinic encompassing cardiovascular risk assessment and management. a new model of care?

Atherosclerosis Supplements ◽

10.1016/j.atherosclerosissup.2018.07.035 ◽

2018 ◽

Vol 34 ◽

pp. e7

Author(s):

A. Goyale ◽

M.G. Misas ◽

D. Roccarina ◽

D.R. Nair ◽

E. Tsochatzis

Keyword(s):

Risk Assessment ◽

Cardiovascular Risk ◽

Liver Disease ◽

Patient Experience ◽

Fatty Liver Disease ◽

Model Of Care ◽

Cardiovascular Risk Assessment ◽

Alcoholic Fatty Liver ◽

Risk Assessment And Management ◽

Alcoholic Fatty Liver Disease

Download Full-text

THU-309-Cardiovascular risk assessment and management improves outcomes in a specialist multidisciplinary non-alcoholic fatty liver disease clinic

Journal of Hepatology ◽

10.1016/s0618-8278(19)30572-9 ◽

2019 ◽

Vol 70 (1) ◽

pp. e296 ◽

Author(s):

Atul Goyale ◽

Marta Guerrero ◽

Laura Iogna Prat ◽

Davide Roccarina ◽

Devaki Nair ◽

...

Keyword(s):

Risk Assessment ◽

Cardiovascular Risk ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Cardiovascular Risk Assessment ◽

Alcoholic Fatty Liver ◽

Disease Clinic ◽

Risk Assessment And Management ◽

Alcoholic Fatty Liver Disease

Download Full-text

Cardiovascular risk assessment in patients attending a pioneering specialist multidisciplinary non-alcoholic fatty liver disease (nafld) clinic: a clinical effectiveness study

Atherosclerosis Supplements ◽

10.1016/j.atherosclerosissup.2018.07.030 ◽

2018 ◽

Vol 34 ◽

pp. e5

Author(s):

A. Goyale ◽

M.G. Misas ◽

D. Roccarina ◽

E. Tsochatzis ◽

D.R. Nair

Keyword(s):

Risk Assessment ◽

Cardiovascular Risk ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Clinical Effectiveness ◽

Effectiveness Study ◽

Cardiovascular Risk Assessment ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease

Download Full-text

Risk assessment of the subclinical hypothyroidism in non-alcoholic fatty liver disease patients with different levels of cardiovascular risk

Blood Heart and Circulation ◽

10.15761/bhc.1000114 ◽

2017 ◽

Vol 1 (3) ◽

Author(s):

Olena Kolesnikova ◽

Valeriya Nemtsova ◽

Anna Isayeva

Keyword(s):

Risk Assessment ◽

Cardiovascular Risk ◽

Liver Disease ◽

Fatty Liver ◽

Subclinical Hypothyroidism ◽

Fatty Liver Disease ◽

Alcoholic Fatty Liver ◽

Different Levels ◽

Alcoholic Fatty Liver Disease

Download Full-text

Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease predicts cardiovascular risk in a large screening cohort

Zeitschrift für Gastroenterologie ◽

10.1055/s-0035-1551776 ◽

2015 ◽

Vol 53 (05) ◽

Author(s):

D Niederseer ◽

A Stadlmayr ◽

U Huber-Schönauer ◽

D Lederer ◽

W Patsch ◽

...

Keyword(s):

Cardiovascular Risk ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Alcoholic Fatty Liver ◽

Non Invasive ◽

Alcoholic Fatty Liver Disease

Download Full-text

Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)

Case Medical Research ◽

10.31525/ct1-nct04191044 ◽

2019 ◽

Author(s):

Keyword(s):

Portal Hypertension ◽

Cardiovascular Risk ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Disease Association ◽

Alcoholic Fatty Liver ◽

Non Invasive ◽

Alcoholic Fatty Liver Disease

Download Full-text

Interplay between non‐alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population

Journal of Gastroenterology and Hepatology ◽

10.1111/jgh.15523 ◽

2021 ◽

Author(s):

Grazia Pennisi ◽

Vito Di Marco ◽

Carola Buscemi ◽

Giovanni Mazzola ◽

Cristiana Randazzo ◽

...

Keyword(s):

Cardiovascular Risk ◽

Liver Disease ◽

General Population ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease

Download Full-text

The effect of combine therapy on the progression of atherosclerosis in patients with non-alcoholic fatty liver disease and high cardiovascular risk

Atherosclerosis ◽

10.1016/j.atherosclerosis.2020.10.762 ◽

2020 ◽

Vol 315 ◽

pp. e242

Author(s):

O. Kolesnikova ◽

K. Vovk ◽

A. Radchenko

Keyword(s):

Cardiovascular Risk ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Combine Therapy ◽

High Cardiovascular Risk ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease ◽

Progression Of Atherosclerosis

Download Full-text

Response to Kawada: Sleep habits and non-alcoholic fatty liver disease: Risk assessment by adjusting confounders

Journal of Diabetes ◽

10.1111/1753-0407.12629 ◽

2018 ◽

Vol 10 (4) ◽

pp. 342-343

Author(s):

Kui Peng ◽

Yuhong Chen

Keyword(s):

Risk Assessment ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Disease Risk ◽

Sleep Habits ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease

Download Full-text

Beneficial Effects of Glucagon-Like Peptide 1 Receptor Agonists on Glucose Control, Cardiovascular Risk Profile, and Non-Alcoholic Fatty Liver Disease. An Expert Opinion of the Italian Diabetes Society

Nutrition Metabolism and Cardiovascular Diseases ◽

10.1016/j.numecd.2021.08.039 ◽

2021 ◽

Author(s):

Raffaele Napoli ◽

Angelo Avogaro ◽

Gloria Formoso ◽

Salvatore Piro ◽

Francesco Purrello ◽

...

Keyword(s):

Cardiovascular Risk ◽

Liver Disease ◽

Fatty Liver Disease ◽

Risk Profile ◽

Cardiovascular Risk Profile ◽

Alcoholic Fatty Liver ◽

Beneficial Effects ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Alcoholic Fatty Liver Disease

Download Full-text

Nutrition and metabolism: non-alcoholic fatty liver disease – pathogenesis, cardiovascular risk and therapy

Current Opinion in Lipidology ◽

10.1097/mol.0b013e3282f41b4f ◽

2008 ◽

Vol 19 (1) ◽

pp. 92-94 ◽

Author(s):

Gerald F Watts ◽

Seng Khee Gan

Keyword(s):

Cardiovascular Risk ◽

Liver Disease ◽

Fatty Liver ◽

Fatty Liver Disease ◽

Disease Pathogenesis ◽

Alcoholic Fatty Liver ◽

Alcoholic Fatty Liver Disease

Download Full-text